Biotickr logobiotickr

Company Description

Opiant is a pharmaceutical company with a mission to create best-in-class medicines for the treatment of addictions and drug overdose. We are headquartered in Santa Monica, with additional offices in London, UK. We were founded in 2009. In 2013, Opiant developed the first FDA-approved, user-friendly nasal naloxone spray. In 2015 this product, NARCAN® Nasal Spray 4mg, became available in the United States and Canada through our licensee, Adapt Pharma (now a part of Emergent BioSolutions). Opiant is now focused on advancing its pipeline alongside receiving royalties from NARCAN® Nasal Spray.

Drug Pipeline

Source: Opiant Pharmaceuticals Inc - 20220925
Asset
Indication
Phase
NARCAN
Opioid Overdose
Reg/Com
 
 
 
 
 
OPNT002
Alcohol Use Disorder
Phase 1
 
 
 
 
 
OPNT003
Opioid Overdose
Phase 3
 
 
 
 
 
OPNT004
Cannabinoid Overdose
Preclinical
 
 
 
 
 

Conversation

0 following
Messages Image
Log in or sign up to join the conversation.

0 Comments on OPNT stock

Newest